Business Context and Reporting Period
This Form 8-K was filed by OrthoPediatrics Corp. on January 3, 2018. The report discloses a material event under Item 7.01 (Regulation FD Disclosure) regarding the launch of a new surgical system.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a product announcement rather than financial performance data.
Material Changes
The primary material change reported is the launch of Titanium PediPlates, which marks the Company's 24th surgical system. This new titanium implant system expands the Company's existing comprehensive physeal tethering offering.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, financial outlook, or specific risk factors beyond the standard regulatory disclosure. The press release associated with this filing is furnished as Exhibit 99.1 but is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the commercial availability and regulatory clearance status of the new Titanium PediPlates system.
- Review the full text of the press release (Exhibit 99.1) for details on market strategy or pricing not included in the 8-K summary.
- Confirm the Company's status as an emerging growth company and its election regarding extended transition periods for accounting standards.